Clinical Trials Browser

Phase 1 × Prostate Cancer Patients With Detectable PSA Following Prostatectomy × Everolimus × Clear all

NCT01548807 2018-08-22

Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy

Phase 1 Completed

Prostate Cancer Patients With Detectable PSA Following Prostatectomy